These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35311373)

  • 21. The three Rs: a restrictive and refutable rigmarole.
    Lansdell H
    Ethics Behav; 1993; 3(2):177-85. PubMed ID: 11652253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressing toward the reduction, refinement and replacement of laboratory animal procedures: thoughts on some encounters with Dr Iain Purchase.
    Balls M
    Toxicol In Vitro; 2004 Apr; 18(2):165-70. PubMed ID: 14757106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growing old disgracefully: the cosmetic use of botulinum toxin.
    Bottrill K
    Altern Lab Anim; 2003 Sep; 31(4):381-91. PubMed ID: 15601243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Dr Hadwen Trust for Humane Research: 39 years of replacement science.
    Farnaud S
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():39-43. PubMed ID: 20105010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brazil Moves Toward the Replacement of Animal Experimentation.
    de Ávila RI; Valadares MC
    Altern Lab Anim; 2019 May; 47(2):71-81. PubMed ID: 31319697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The replacement of animal testing: ethical issues and practical realities.
    Balls M
    Int J Cosmet Sci; 1991 Feb; 13(1):23-8. PubMed ID: 11659564
    [No Abstract]   [Full Text] [Related]  

  • 28. Strategies for replacing animals in biomedical research.
    Broadhead CL; Bottrill K
    Mol Med Today; 1997 Nov; 3(11):483-7. PubMed ID: 9430783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developments on the implementation of the Three Rs in research and education.
    van Zutphen LF; van der Valk JB
    Toxicol In Vitro; 2001; 15(4-5):591-5. PubMed ID: 11566596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European experimental animal use declines ever so slightly.
    Hudson M; Balls M
    Altern Lab Anim; 2010 Dec; 38(6):529-32. PubMed ID: 21275474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reporting the implementation of the Three Rs in European primate and mouse research papers: are we making progress?
    Taylor K
    Altern Lab Anim; 2010 Dec; 38(6):495-517. PubMed ID: 21275472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animals and alternatives: societal expectations and scientific need.
    Goldberg AM
    Altern Lab Anim; 2004 Dec; 32(6):545-51. PubMed ID: 15757493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of non-human primates in biological and medical research: evidence submitted by FRAME to the Academy of Medical Sciences/Medical Research Council/Royal Society/Wellcome Trust Working Group.
    Bhogal N; Hudson M; Balls M; Combes RD
    Altern Lab Anim; 2005 Oct; 33(5):519-27. PubMed ID: 16268763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation and regulatory acceptance of alternatives.
    Hill RN; Stokes WS
    Camb Q Healthc Ethics; 1999; 8(1):73-9. PubMed ID: 9924621
    [No Abstract]   [Full Text] [Related]  

  • 36. Russell and Burch's 3Rs then and now: the need for clarity in definition and purpose.
    Tannenbaum J; Bennett BT
    J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):120-32. PubMed ID: 25836957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scientific procedures on living animals in Great Britain 2003.
    Altern Lab Anim; 2005 Apr; 33(2):83-8. PubMed ID: 16189908
    [No Abstract]   [Full Text] [Related]  

  • 38. Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing.
    Törnqvist E; Annas A; Granath B; Jalkesten E; Cotgreave I; Öberg M
    PLoS One; 2014; 9(7):e101638. PubMed ID: 25054864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation and regulatory acceptance of new carcinogenicity tests.
    Spielmann H
    Toxicol Pathol; 2003; 31(1):54-9. PubMed ID: 12597449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. It's Time to Include Harm to Humans in Harm-Benefit Analysis - But How to Do It, That is the Question.
    Balls M
    Altern Lab Anim; 2021 Sep; 49(5):182-196. PubMed ID: 34836474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.